FR2610932B1 - Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament - Google Patents

Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament

Info

Publication number
FR2610932B1
FR2610932B1 FR888801782A FR8801782A FR2610932B1 FR 2610932 B1 FR2610932 B1 FR 2610932B1 FR 888801782 A FR888801782 A FR 888801782A FR 8801782 A FR8801782 A FR 8801782A FR 2610932 B1 FR2610932 B1 FR 2610932B1
Authority
FR
France
Prior art keywords
medicine
novel
preparation
piperazinecarboxylic acid
piperazinecarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR888801782A
Other languages
English (en)
French (fr)
Other versions
FR2610932A1 (fr
Inventor
Bernhard Aebischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2610932A1 publication Critical patent/FR2610932A1/fr
Application granted granted Critical
Publication of FR2610932B1 publication Critical patent/FR2610932B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR888801782A 1987-02-18 1988-02-12 Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament Expired - Lifetime FR2610932B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (2)

Publication Number Publication Date
FR2610932A1 FR2610932A1 (fr) 1988-08-19
FR2610932B1 true FR2610932B1 (fr) 1990-11-16

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888801782A Expired - Lifetime FR2610932B1 (fr) 1987-02-18 1988-02-12 Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament

Country Status (28)

Country Link
JP (1) JPH0723387B2 (hu)
KR (1) KR960015190B1 (hu)
AT (1) AT391320B (hu)
AU (1) AU613009B2 (hu)
BE (1) BE1002427A3 (hu)
CA (1) CA1327799C (hu)
CH (1) CH675125A5 (hu)
CY (1) CY1739A (hu)
DE (1) DE3804936C2 (hu)
DK (1) DK168441B1 (hu)
ES (2) ES2011319A6 (hu)
FI (1) FI86733C (hu)
FR (1) FR2610932B1 (hu)
GB (2) GB8703749D0 (hu)
GR (1) GR1002471B (hu)
HK (1) HK142093A (hu)
HU (2) HU199858B (hu)
IE (1) IE59098B1 (hu)
IL (1) IL85436A0 (hu)
IT (1) IT1219447B (hu)
LU (1) LU87129A1 (hu)
MY (1) MY103206A (hu)
NL (1) NL8800412A (hu)
NZ (1) NZ223529A (hu)
PH (1) PH25512A (hu)
PT (1) PT86776B (hu)
SE (1) SE467256B (hu)
ZA (1) ZA881146B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
EP0826032A1 (de) * 1995-05-08 1998-03-04 Lonza Ag Biotechnologisches verfahren zur herstellung von r-alpha-piperazincarbonsäure und s-alpha-piperazincarbonsäureamid
HUP0100048A3 (en) 1997-05-12 2002-12-28 Ortho Mcneil Pharm Inc Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
IT8847631A0 (it) 1988-02-12
JPH0723387B2 (ja) 1995-03-15
ZA881146B (en) 1989-10-25
GB2201676B (en) 1991-01-02
KR880009944A (ko) 1988-10-06
DK168441B1 (da) 1994-03-28
FI86733B (fi) 1992-06-30
AT391320B (de) 1990-09-25
JPS63203691A (ja) 1988-08-23
GB8703749D0 (en) 1987-03-25
LU87129A1 (fr) 1988-09-20
GR1002471B (el) 1996-11-15
PH25512A (en) 1991-07-24
DE3804936C2 (de) 1997-02-13
CA1327799C (en) 1994-03-15
DK79688A (da) 1988-08-19
FR2610932A1 (fr) 1988-08-19
ES2011319A6 (es) 1990-01-01
IL85436A (hu) 1992-12-01
DE3804936A1 (de) 1988-09-01
SE8800541D0 (sv) 1988-02-17
ES2021904A6 (es) 1991-11-16
FI880744A (fi) 1988-08-19
BE1002427A3 (fr) 1991-02-05
GB8803438D0 (en) 1988-03-16
HU199858B (en) 1990-03-28
DK79688D0 (da) 1988-02-16
SE467256B (sv) 1992-06-22
HU211269A9 (en) 1995-11-28
SE8800541A (hu) 1988-08-19
AU1175888A (en) 1988-08-25
CY1739A (en) 1995-10-20
NZ223529A (en) 1991-02-26
IL85436A0 (en) 1988-07-31
IT1219447B (it) 1990-05-18
NL8800412A (nl) 1988-09-16
CH675125A5 (hu) 1990-08-31
FI86733C (fi) 1992-10-12
PT86776A (pt) 1988-03-01
HK142093A (en) 1994-01-07
IE59098B1 (en) 1994-01-12
ATA36788A (de) 1990-03-15
FI880744A0 (fi) 1988-02-17
MY103206A (en) 1993-05-29
PT86776B (pt) 1992-05-29
GR880100084A (el) 1988-12-16
KR960015190B1 (ko) 1996-11-01
IE880413L (en) 1988-08-18
AU613009B2 (en) 1991-07-25
GB2201676A (en) 1988-09-07
HUT49361A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
FR2611707B1 (fr) Nouveau carbamate de phenyle, sa preparation et son utilisation comme medicament
DK89090D0 (da) Farmaceutisk praeparat
FR2620451B1 (fr) Nouveaux inhibiteurs de la renine, leur preparation et leur utilisation comme medicaments
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
IS3339A7 (is) Ný efnablanda lyfja
DK705488A (da) Farmaceutisk praeparat
FR2610932B1 (fr) Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament
FR2560196B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
DK229387D0 (da) Retinoesyreestere, deres fremstilling og farmaceutiske og kosmetiske praeparater deraf
DK250088A (da) Ophthalmologisk praeparat
BE896590A (fr) Nouveaux azepino-indoles leur preparation et leur utilisation comme medicaments
FR2608159B1 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments
FR2544718B1 (fr) Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
DK139388D0 (da) Farmaceutisk praeparat
FR2617166B1 (fr) Nouvelle 8a-acylaminoergoline, sa preparation et son utilisation comme medicament
DK276288A (da) Farmaceutisk praeparat
EP0283948A3 (en) Polymers modified by acid end groups, their manufacture and their use
FR2612185B1 (fr) Derives oxo-isoindolinyliques optiquement actifs, leur preparation et leur utilisation comme medicaments
ES2012326A4 (es) Monoesteres del acido griseolico, su preparacion y empleo
IL82219A0 (en) 3-amino-2-cyano-acrylic acid esters,their preparation and their use as herbicides
FR2508044B1 (fr) Acide 2',4'-difluoro-4-phosphonoxy (1,1'-diphenyle) - 3-carboxylique, sa preparation et son utilisation comme medicament
JPS6442470A (en) Guanidinecarboxylic acid esters, manufacture and medicinal composition
AU7684587A (en) Substituted phenylacetic acid esters, their preparation and their use as insecticides and acaricides
DK580288A (da) Farmaceutisk praeparat indeholdende imidazol-2-thioncarboxamider
FR2610322B1 (fr) Nouveaux derives de la pilocarpine, leur preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse